Cargando…
Efficacy of antiviral therapy during the second or the third trimester for preventing mother-to-child hepatitis B virus transmission: a systematic review and meta-analysis
For pregnant women with high viral load, antiviral therapy has been administered in addition to active and passive immune prophylaxis as a crucial adjunctive therapy to interrupt mother-to-child hepatitis B virus (HBV) transmission (MTCT). However, the time of antiviral therapy onset remains controv...
Autores principales: | Yang, Xiuhan, Zhong, Xiaozhu, Liao, Huihua, Lai, Yongchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032012/ https://www.ncbi.nlm.nih.gov/pubmed/32074216 http://dx.doi.org/10.1590/S1678-9946202062013 |
Ejemplares similares
-
Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission
por: Burman, Blaire E., et al.
Publicado: (2017) -
Strategies to Prevent Mother-to-child Transmission of Hepatitis B Virus
por: Sintusek, Palittiya, et al.
Publicado: (2023) -
Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters
por: Wang, Jing, et al.
Publicado: (2020) -
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)
por: Liu, Zhihua, et al.
Publicado: (2022) -
1144. Prevention of Mother-to-Child Transmission of Hepatitis B at UNC Hospitals
por: Sayre, Wesley M
Publicado: (2020)